Cargando…
The beneficial effect over 3 years by pictorial information to patients and their physician about subclinical atherosclerosis and cardiovascular risk: Results from the VIPVIZA randomized clinical trial
OBJECTIVE: Non-adherence to guidelines and preventive measures is a major challenge, particularly so to obtain long-term adherence to lifestyle changes and recommended medication. The objective was to investigate if pictorial information regarding subclinical carotid atherosclerosis provided to indi...
Autores principales: | Bengtsson, Anna, Norberg, Margareta, Ng, Nawi, Carlberg, Bo, Grönlund, Christer, Hultdin, Johan, Lindahl, Bernt, Lindahl, Bertil, Nordin, Steven, Nyman, Emma, Wennberg, Patrik, Wester, Per, Näslund, Ulf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387279/ https://www.ncbi.nlm.nih.gov/pubmed/34611639 http://dx.doi.org/10.1016/j.ajpc.2021.100199 |
Ejemplares similares
-
Increased knowledge makes a difference! – general practitioners’ experiences of pictorial information about subclinical atherosclerosis for primary prevention: an interview study from the VIPVIZA trial
por: Bengtsson, Anna, et al.
Publicado: (2021) -
Time to initiation of lipid-lowering drugs for subclinical atherosclerosis: sub-study of VIPVIZA randomized controlled trial, with single-arm cross-over
por: Holmberg, Henrik, et al.
Publicado: (2022) -
Multi-view carotid ultrasound is stronger associated with cardiovascular risk factors than presence of plaque or single carotid intima media thickness measurements in subclinical atherosclerosis
por: Bengtsson, Anna, et al.
Publicado: (2023) -
Prescription of Lipid-Lowering and Antihypertensive Drugs Following Pictorial Information About Subclinical Atherosclerosis: A Secondary Outcome of a Randomized Clinical Trial
por: Sjölander, Maria, et al.
Publicado: (2021) -
Cognitive and emotional reactions to pictorial-based risk communication on subclinical atherosclerosis: a qualitative study within the VIPVIZA trial
por: Andersson, Elin M., et al.
Publicado: (2023)